Sarepta Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2025
Total Assets: $3.35B
Liabilities Breakdown FY2025
Total Liabilities: $2.21B
Asset Breakdown
Total Assets: $3.35B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $801.3M | 23.9% |
| Accounts Receivable | $398.2M | 11.9% |
| Inventory | $914.7M | 27.3% |
| Property, Plant & Equipment | $345.1M | 10.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $28.9M | 0.9% |
| Other Assets | $861.4M | 25.7% |
Liabilities Breakdown
Total Liabilities: $2.21B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $280.8M | 12.7% |
| Long-Term Debt | $829.0M | 37.5% |
| Other Liabilities | $1.10B | 49.8% |